Holen Sie sich die Stockscreener-App
0.00
100.00%
-15.68
Reshape Lifesciences Inc Aktie (RSLS) Neueste Nachrichten
Vyome Holdings, Inc. shares fall 15.75% premarket after completing merger with ReShape Lifesciences. - AInvest
Vyome Therapeutics Completes Merger with ReShape Lifesciences; Nasdaq Debut Under Ticker HIND - Sahyadri Startups
Vyome Holdings, Inc. shares fall 8.93% premarket after closing merger transaction with ReShape Lifesciences Inc. - AInvest
Vyome Therapeutics' Strategic Merger with ReShape Lifesciences: A Launchpad for US-India Biotech Synergy - AInvest
Vyome Therapeutics Completes Merger with ReShape Lifesciences - AInvest
Vyome Therapeutics Completes Merger With ReShape Lifesciences - MarketScreener
Reshape Lifesciences Reports Q2 2025 Financial Results - TipRanks
Breaking: Clinical-Stage Biotech Vyome Finalizes ReShape Merger, Set for Nasdaq Debut as HIND Tomorrow - Stock Titan
ReShape Lifesciences Inc. SEC 10-Q Report - TradingView
ReShape Lifesciences (RSLS.O) Surges 28.4%: Is It a Short Squeeze or a New Narrative? - AInvest
ReShape Lifesciences Skyrockets 25.47%—What’s Fueling This Pre-Market Surge? - AInvest
Vyome To Begin Trading On Nasdaq Via Reverse Merger With ReShape Lifesciences Tomorrow - Nasdaq
ReShape Lifesciences Surges 31% on Nasdaq Merger Approval: A New Era for Vyome Holdings? - AInvest
ReShape Lifesciences Stock Rocketed 37% Today – Here’s Why - MSN
Why Did ReShape Lifesciences Plunge 8.75% Amid Vyome Merger? - AInvest
ReShape Lifesciences Approves Asset Sale and Merger - TipRanks
Vyome Therapeutics Inc. completed the acquisition of ReShape Lifesciences Inc. in a reverse merger transaction. - MarketScreener
Health Care Stocks Climb As Deals And Results Grab Attention - Finimize
ReShape Lifesciences Soars 66.99% on Nasdaq Merger Approval: A Biotech Merger Sparking Market Frenzy - AInvest
ReShape Lifesciences' Merger With Vyome Therapeutics Receives Nasdaq Approval for Listing - MarketScreener
ReShape Lifesciences Stock Rocketed 37% Today – Here’s Why By Stocktwits - Investing.com India
Vyome announces Nasdaq approval of merger with ReShape Lifesciences - TipRanks
Vyome Therapeutics Announces Nasdaq Approval for Merger with ReShape Lifesciences - AInvest
Vyome Announces Nasdaq Approval of Merger with ReShape Lifesciences, Set to Begin Trading as HIND - Business Wire
Recovery Setup Building in ReShape Lifesciences Inc. Experts SayJuly 2025 Opening Moves & Verified Trade Idea Suggestions - sundaytimes.kr
ReShape Lifesciences Stock Rocketed 61% Today – Here’s Why - Stocktwits
Vyome Therapeutics Sets Board To Lead Reshape Lifesciences Post-Close; New Entity To Trade As Vyome Holdings Under Ticker Symbol HIND - 富途牛牛
MIT AI Experts Take Control: Inside Vyome's Complete Board Overhaul Before Major NASDAQ Debut - Stock Titan
How ReShape Lifesciences Inc. stock performs during market volatilityFree Portfolio Optimization Guide - newsyoung.net
ReShape Lifesciences shareholders approve merger with Vyome Therapeutics - MSN
ReShape Lifesciences Approves Asset Sale and Merger with Vyome Therapeutics - AInvest
ReShape Lifesciences RSLS 2025Q2 Earnings Preview Upside Potential on Strategic Reshape Initiatives - AInvest
ReShape Lifesciences Shareholders Approve Merger with Vyome Therapeutics, Ticker Symbol to Change to HIND - AInvest
ReShape announces shareholder approval of Vyome merger - TipRanks
ReShape Lifesciences Announces Shareholder Approval of Merger with Vyome Therapeutics - MarketScreener
How does ReShape Lifesciences Inc. generate profit in a changing economyAccess high-quality stock research instantly - Jammu Links News
What are the latest earnings results for ReShape Lifesciences Inc.Navigate the market with precision tools - Jammu Links News
What are analysts’ price targets for ReShape Lifesciences Inc. in the next 12 monthsRapid-fire capital growth - Jammu Links News
Is it the right time to buy ReShape Lifesciences Inc. stockGet real-time alerts on top-performing stocks - Jammu Links News
How strong is ReShape Lifesciences Inc. company’s balance sheetExceptional trading results - Jammu Links News
Is ReShape Lifesciences Inc. a growth stock or a value stockCapitalize on momentum-driven opportunities - Jammu Links News
What is the dividend policy of ReShape Lifesciences Inc. stockUnlock expert trading strategies for growth - Jammu Links News
What are the technical indicators suggesting about ReShape Lifesciences Inc.Accelerated profit realization - Jammu Links News
What are ReShape Lifesciences Inc. company’s key revenue driversSpectacular growth rates - Jammu Links News
When is ReShape Lifesciences Inc. stock expected to show significant growthBuild a winning investment strategy today - Jammu Links News
What institutional investors are buying ReShape Lifesciences Inc. stockAchieve breakthrough financial results - Jammu Links News
Why ReShape Lifesciences Inc. stock attracts strong analyst attentionLow Risk Picks for Daily Trading Released - beatles.ru
ReShape Lifesciences Inc. Pullback Analyzed — Is It Time to ExitAI Forecast for Trending Stocks Indicates Upside - metal.it
ReShape Lifesciences Inc. Forms Double Bottom Pattern — Eyes on BreakoutWatchlist for Smart Swing Trading Updated - metal.it
Published on: 2025-07-29 19:35:19 - metal.it
Options Data Show Bullish Bias in ReShape Lifesciences Inc.Pattern Alert With ROI Driven Strategy Shared - metal.it
ReShape Lifesciences Inc. Inches Toward Key Resistance — Will It BreakReal Trader Watchlist of Hot Stocks Released - metal.it
1.74%
0.24%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):